97. Ulcerative colitis Clinical trials / Disease details


Clinical trials : 2,527 Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04000139
(ClinicalTrials.gov)
April 1, 201924/6/2019Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative ColitisA Multi-center, Multi-national, Randomized, Double-blind, Placebo Controlled, Parallel Group, Phase IIa Study to Evaluate the Efficacy, Safety and Tolerability of an Anthocyanin-rich Extract (ACRE) in Patients With Ulcerative ColitisUlcerative ColitisDrug: Standardized anthocyanin-rich extract;Drug: PlaceboUniversity of ZurichSwiss National Science Foundation;The Broad FoundationCompleted18 YearsN/AAll48Phase 2Switzerland